Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
People say it wouldn’t have mattered if they PR’d the changes back in December, I disagree.
If they had issued a PR back then stating something like “Avatar trial upgraded to pIII on FDA guidance “
Then explain about the endpoints, that were infact more rigorous.
When results were released, there would be no surprises and they did infact, meet the new, harder endpoints,
What ammo would adam phukstein have to smear the results!!!
Author agrees with Anavex. Pretty decent article explaining the confusion.
Not a peep about PDD/PD in a long time. Or Fragile X or the undisclosed rare disease for that matter.
You got that right, sure was a flat line for trading millions of shares.
Blackrock has major ties to DC. Perhaps if they are the ones accumulating, AVXL might benefit in the long run.
BLACKROCK now owns 6.90% of the company…….follow the money.
Over 10m shares traded hands the last two days. Someone is accumulating
I have always cut Missling a lot of slack, but I see no reason why he didn’t issue a strongly worded PR this morning to clear this mess up.
Now back to the single digits
Looks like no PR from the company!
I really do not understand why he wouldn’t. I guess he figured the response to IBD was enough.
COME ON MAN!!!
Okay fair enough, thanks for the response
It’s very disappointing that we were just in the 20s with the hope of maybe seeing 30s with good Avatar data.
Now back to single digits?….sad
What happened to you raja? Lately you have been posting about all of Anavex’s competition now you are encouraging people to sell??
This was a planned bear raid.. period!
AF has been covering biotech for years, he knows damn well a company can’t arbitrarily change endpoints to make their trial pass. If it was that easy, there would be very few failures.
Hopefully, he points this out on the upcoming earnings call. Emphasis that is was a harder endpoint at the FDAs request.
Agreed nidan.. criminal
Maybe ffrol and others like him will see the light on how corrupt ws is!
Down 18% on great news. Sounds legit
Don’t forget, market manipulation is just made up isn’t that right ffrol?
Any thoughts on Blackrock being AVXL’s largest institutional shareholder. They have significant ties to DC and the Binden administration.
In the corrupt world that we live in, their influence might be an asset for Anavex.
On the subject of trial analysis, after they get the first couple of trials under their belt, will the time to analyze the results become faster and more streamlined or is each trial completely different.?
Thanks Sokol, great info. Now you know that you are going get a lecture from ffrol and investor for merely bringing up the subject of treating Covid with Anavex’s drugs!
This is not a magic bean and we need to focus on Rett!
I was thinking the same. Maybe we are finally starting to see signs of what our two retired FDA employees have been up to.
FUD.. “The ct.gov update could be negative - data was p>0.05 using the initial pre-specified statistical analysis plan but with a few tweaks and differnt analysis, msybe even subsets, then p<0.05. This allows a positive PR but might be perceived as a negative once the words are digested. Missling could be the greatest (Bayesian) sharpshooter in Texas but eventually runs out of paint.
I think we will find out within the next 2 weeks “
Sure Doc, maybe A2-73 might be approved in 5-10 years
I’m still a little confused on how they were able to change the “n”, endpoints, and ph2a/3>3 AFTER the trial has already been completed.
They obviously had very positive feedback from the FDA .
Bodes well for an earlier approval then expected.
At least now we have a pretty good idea on what is taking so long to release the TLD.
I think this is a bigger deal than most people realize.
Looks like we might be getting an earlier approval then we expected. Fingers crossed!
I typed that address into Zillow, however, after digging deeper, that’s probably not it.
Sorry for the confusion.
630 5TH AVE, NY,NY
We're pleased to offer for sublease 4,940 SF of prime office space available at 630 Fifth Avenue, AKA 45 Rockefeller Plaza, 23rd floor. Fully built out turnkey opportunity. 4 year sublet with opportunity for a new direct lease.Features include: *Complete turnkey opportunity*Includes full suite of furniture including all desks, chairs, credenzas, and audio/visual equipment*Upgraded wiring and IT*8 offices includes 2 executive offices, conference room, pantry/kitchen, and 6 station cubicles. See floor plan for complete space plan*Direct access to Rockefeller Center concourse, including subway lines*LA Fitness center on site* Marble public corridors* 24 hour/7 day access * Renovated common areas* Centrally located 725-car garage* Direct subway access* Walk to Grand Central Station and Port Authority bus terminal* Convenient to Penn Station and PATH New Jersey trains
WHAT IF the TGD would have released the RETT data last week still “on time”?
Maybe we would have spiked to $20 something.
Then what? With the market meltdown, we might have been right back in the mid teens anyway?
At least we still have the data release to look forward to if the general market recovers a little.
Investor, you are going to get a big,shiny trophy for your Feb’ish call.
Now tell all of us amateurs when Excellence TLD will be announced !
From BBB on st twts-
“And IR today (just
now). .said.. Excellence is
enrolling normally now!: I said
did the FDA stop enrollment. he
said no, he believed Australia
lockdowns kept that down, but
now Excellence is enrolling. WILL
ALZHEIMER'S results be on time??
He said to expect that on time.
He said they have updated
technology and staff to make that
happen as expected. Of course
rett. Is any day here. when rett
Avatar release is out we will get a
full update on the rett program.
They continue to feel very
positive on Rett results.”
I copied it the way it was posted on st twits. If the the first part was there, I certainly would have included it. Definitely sounded encouraging !
“The start of the trial has been delayed slightly but
rest assured everything is still in place for
enrolment to begin in late January 2022.
We will be in touch via email as soon as we have
confirmed trial sites and start dates.
Thank you for your patience”
From the Reverse Rett Facebook page
Maybe the second dose dependent positive results will green light the other trials?
Is it possible that the AVATAR TLD Is the holdup on rest of the pipeline updates?
Perhaps with convincing data, Fragile X and the secret rare disorder will be mixed into a basket trial?
It’s strange that there hasn’t been a peep about PD/PDD in months.
Maybe the FDA needed to see more proof of A2-73s MOA?
Interesting to watch the change taking place on this MB with a decline in share price!
We just got great news about A3-71, which in my opinion, will be the shining star of Anavex’s future.
More huge markets , a shorter duration basket trial sounds great to me.
Avatar will be out in a few days most likely, and it should be great!
Now some here are ready to throw in the towel?
If you have been around since before the R/S. We have been through a lot worse.
Suck it up or get out!
I own a bunch of NWBO as well. I would be curious to know how many AVXL longs also own NWBO?
Another game changing, disruptive baby bio.
AVXL
NWBO
CRYPTO/ Metaverse…… $$$$$$$$$$$$$
Lots of doom and gloom here! ( but not from Anavex) Sounds like a good time to load up!
The XBI hit it’s high of 173 on February 8th
Today it’s 99, that’s a huge retrace.
Hopefully, the sector will come back into favor when AVXL starts hitting on all cylinders!
How many times have we seen this movie over the past few years?
Big expectations for a big conference or CC followed by disappointment.
11:15EST!!!!!!!
I don’t expect it to go much lower than where it is unless Avatar drags out much longer.
Don’t want to be a Debbie downer, but I have lowered my near term PPS expectations. I hope I’m wrong but I’m only expecting short term pops from these trial reports.
I think it’s going to take a partnership with a deep pocket BP or revenue to get respect from Wall Street and the media.
With approvals and sales, the PPS should be in the hundreds however!
Longer term, PPS should be mind boggling.
Hopefully with good Avatar results we can get this back up to $20 bucks!